[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPS5721312A - Breathable ointment - Google Patents

Breathable ointment

Info

Publication number
JPS5721312A
JPS5721312A JP9525880A JP9525880A JPS5721312A JP S5721312 A JPS5721312 A JP S5721312A JP 9525880 A JP9525880 A JP 9525880A JP 9525880 A JP9525880 A JP 9525880A JP S5721312 A JPS5721312 A JP S5721312A
Authority
JP
Japan
Prior art keywords
organic compound
ointment
fluorinated organic
pref
main component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9525880A
Other languages
Japanese (ja)
Other versions
JPS6342601B2 (en
Inventor
Ryozo Watanabe
Takashi Imagawa
Yasuo Motoyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Priority to JP9525880A priority Critical patent/JPS5721312A/en
Publication of JPS5721312A publication Critical patent/JPS5721312A/en
Publication of JPS6342601B2 publication Critical patent/JPS6342601B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

PURPOSE: To provide the titled ointment having protecting activity to the injured skin surface, and at the same time, sufficiently high permeability to enable the ample supply of oxygen to the skin surface to effect the remedy of the injured part, by using a fluorinated organic compound as a main component.
CONSTITUTION: The objective ointment contains a fluorinated organic compound as a main component, and pref. an emulsifier and water as optional components. The fluorinated organic compound is those having oxygen-carrying capability, pref. a 8W12C compound. The degree of fluorination of the fluorinated organic compound is larger the better, esp. a perfluoro-organic compound is preferable. The amount of the main component is the ointment is 40W70wt%, pref. 50W 60wt%, and that of the emulsifier is generally 6W13wt%, and water is 15W40wt%.
COPYRIGHT: (C)1982,JPO&Japio
JP9525880A 1980-07-12 1980-07-12 Breathable ointment Granted JPS5721312A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9525880A JPS5721312A (en) 1980-07-12 1980-07-12 Breathable ointment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9525880A JPS5721312A (en) 1980-07-12 1980-07-12 Breathable ointment

Publications (2)

Publication Number Publication Date
JPS5721312A true JPS5721312A (en) 1982-02-04
JPS6342601B2 JPS6342601B2 (en) 1988-08-24

Family

ID=14132731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9525880A Granted JPS5721312A (en) 1980-07-12 1980-07-12 Breathable ointment

Country Status (1)

Country Link
JP (1) JPS5721312A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51144791A (en) * 1975-06-09 1976-12-13 Mitsubishi Chem Ind Ltd Process for preparing l-cystine derivatives
US5480914A (en) * 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US6458376B1 (en) 1990-09-27 2002-10-01 Allergan, Inc. Nonaqueous fluorinated drug delivery suspensions
WO2020064549A1 (en) * 2018-09-27 2020-04-02 Novaliq Gmbh Lipid barrier repair
US11273174B2 (en) 2017-04-21 2022-03-15 Novaliq Gmbh Iodine compositions
US11510855B2 (en) 2018-09-27 2022-11-29 Dermaliq Therapeutics, Inc. Topical sunscreen formulation
US11723861B2 (en) 2017-09-27 2023-08-15 Novaliq Gmbh Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
US11844836B2 (en) 2011-05-25 2023-12-19 Dermaliq Therapeutics, Inc. Topical pharmaceutical composition based on semifluorinated alkanes
US12128010B2 (en) 2015-09-30 2024-10-29 Novaliq Gmbh Semifluorinated compounds and their compositions

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51144791A (en) * 1975-06-09 1976-12-13 Mitsubishi Chem Ind Ltd Process for preparing l-cystine derivatives
JPS5813155B2 (en) * 1975-06-09 1983-03-11 三菱化学株式会社 L- Cysteine
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US6458376B1 (en) 1990-09-27 2002-10-01 Allergan, Inc. Nonaqueous fluorinated drug delivery suspensions
US5480914A (en) * 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
US11844836B2 (en) 2011-05-25 2023-12-19 Dermaliq Therapeutics, Inc. Topical pharmaceutical composition based on semifluorinated alkanes
US12128010B2 (en) 2015-09-30 2024-10-29 Novaliq Gmbh Semifluorinated compounds and their compositions
US11273174B2 (en) 2017-04-21 2022-03-15 Novaliq Gmbh Iodine compositions
US11723861B2 (en) 2017-09-27 2023-08-15 Novaliq Gmbh Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
WO2020064549A1 (en) * 2018-09-27 2020-04-02 Novaliq Gmbh Lipid barrier repair
US11510855B2 (en) 2018-09-27 2022-11-29 Dermaliq Therapeutics, Inc. Topical sunscreen formulation
US12029757B2 (en) 2018-09-27 2024-07-09 Dermaliq Therapeutics, Inc. Lipid barrier repair

Also Published As

Publication number Publication date
JPS6342601B2 (en) 1988-08-24

Similar Documents

Publication Publication Date Title
JPS5266551A (en) Stabilizer for plastics
JPS5721312A (en) Breathable ointment
JPS542336A (en) Preventive and remedy for viral diseases
JPS53148518A (en) Stabilized prostaglandin e composition and its preparation
JPS52103002A (en) Long-noise vertical pump
JPS5423126A (en) Agricultural and horticultural fungicide
JPS5341428A (en) Miticidal composition
JPS531679A (en) Deodorizing method
JPS5423132A (en) Analgesic composition
JPS521029A (en) Method for increasing activities of quick firing aerosols
JPS53111395A (en) Preparation of nonfoamable urethane elastomer
JPS53102296A (en) Stabilized solution of hydrogen peroxide
JPS54137478A (en) Ozone removal
JPS5321857A (en) Method of treating ammonia-containing liquid
JPS5264427A (en) Growth regulator composition for tobacco axillary buds
JPS53115554A (en) Method of treating malodorous gas in grit chamber
JPS5742620A (en) Novel antiulcer agent
JPS5423128A (en) Agricultural and horticultural fungicide
JPS534650A (en) Apparatus fur facial treatment
EP0041298A3 (en) Composition for inhibiting or preventing the development of suckers in tobacco plants
JPS5435208A (en) Stabilization of prostaglandin and prostaglandin-ramily compound
JPS5742606A (en) Controlling agent against rust of chrysanthemum and controlling method
JPS51124050A (en) Treatment method of waste water containing formaldehyde
JPS5346968A (en) Novel hexadecapeptides
JPS53113021A (en) Controlling agents against plant pests caused by virus